Page last updated: 2024-08-26

diflucortolone valerate and Chronic Disease

diflucortolone valerate has been researched along with Chronic Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brunner, N; Yawalkar, S1
Carreon-Gavino, M; Costales, A; Geraldez, MC; Hoppe, G1

Trials

2 trial(s) available for diflucortolone valerate and Chronic Disease

ArticleYear
A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicus.
    Journal of the American Academy of Dermatology, 1991, Volume: 25, Issue:6 Pt 2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Austria; Chronic Disease; Clobetasol; Dermatitis, Atopic; Diflucortolone; Double-Blind Method; Female; Humans; Male; Middle Aged; Neurodermatitis; Ointments; Patient Satisfaction; Remission Induction; Vasoconstrictor Agents; Wound Healing

1991
Diflucortolone valerate ointment with and without occlusion in lichen simplex chronicus.
    International journal of dermatology, 1989, Volume: 28, Issue:9

    Topics: Chronic Disease; Diflucortolone; Fluocortolone; Humans; Lichen Planus; Occlusive Dressings; Ointments; Random Allocation

1989